Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices

Journal of General Internal Medicine

Volumn 24, Issue 10, 2009, Pages 1123-1129

  Boulware, L Ebony ^a,b,c   Carson, Kathryn A ^b   Troll, Misty U ^a,c   Powe, Neil R ^a,b,c   Cooper, Lisa A ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adherence; Attitudes; Chronic kidney disease; Perceived susceptibility; Primary care

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF CONCEPT;

ADULT; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS; SELF CONCEPT;

EID: 77953919606     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1086-6     Document Type: Article

References (44)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17): 2038-47. (Pubitemid 350074801)
2. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20): 2049-60. (Pubitemid 40664306)
3. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142(7): 497-505.
4. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14(11): 2934-41. (Pubitemid 37305656)
5. Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med. 2005;165(19): 2299-304. (Pubitemid 41549928)
6. Hostetter TH, Lising M. National kidney disease education program. J Am Soc Nephrol. 2003;14(7 Suppl 2):S114-116. (Pubitemid 36750504)
7. NKDEP Urges Primary Care for People with CKD. NIH Publication No. 08-4531 [http://kidney.niddk.nih.gov/about/Research-Updates/ KidneyDiseaseWin08/6.htm. Accessed August, 2009]
8. Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45(6): 1119-24. (Pubitemid 40770315)
9. Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care. 1996;34(9): 873-89. (Pubitemid 126465547)
10. Kirkman MS, Williams SR, Caffrey HH, Marrero DG. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care. 2002;25(11): 1946-51. (Pubitemid 41071049)
11. Cooper LA, Roter DL, Bone LR, et al. A randomized controlled trial of interventions to enhance patient-physician partnership, patient adherence and high blood pressure control among ethnic minorities and poor persons: study protocol NCT00123045. Implement Sci. 2009;4:7.
12. Davis TC, Crouch MA, Long SW, et al. Rapid assessment of literacy levels of adult primary care patients. Fam Med. 1991;23(6): 433-5.
13. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15(3): 90-6.
14. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289 (19): 2560-72. (Pubitemid 37430158)
15. Expert Panel on the Identification E, Treatment of Overweight in A. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr. 1998;68(4): 899-917.
16. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280 (19): 1690-1. (Pubitemid 28532993)
17. Huber PJ. The Behavior of Maximum Likelihood Estimates under Nonstandard Conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: University of California Press;1967: 221-3.
18. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 48: 817-30.
19. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56: 645-6. (Pubitemid 30422662)
20. Rogers WH. Regressions standard errors in clustered samples. Stata Tech Bull. 1993;13: 19-23.
21. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16(1): 180-8. (Pubitemid 43073171)
22. Waterman AD, Browne T, Waterman BM, Gladstone EH, Hostetter T. Attitudes and behaviors of African Americans regarding early detection of kidney disease. Am J Kidney Dis. 2008;51(4): 554-62. (Pubitemid 351400842)
23. National Kidney F. Annual data report: Kidney Early Evaluation Program. American Jounal of Kidney Diseases. 2003;42(5): Supplement 4.
24. Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis. 2006;47(1): 72-7. (Pubitemid 41828268)
25. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48(2): 192-204. (Pubitemid 44069609)
26. Davis RE, Dolan G, Thomas S, et al. Exploring doctor and patient views about risk communication and shared decision-making in the consultation. Health Expect. 2003;6(3): 198-207. (Pubitemid 37087132)
27. Royak-Schaler R, Lemkau JP, Ahmed SM. Discussing breast cancer risk in primary care. J Am Med Womens Assoc. 2002;57(2): 115-6.
28. Buchanan AH, Skinner CS, Rawl SM, et al. Patients' interest in discussing cancer risk and risk management with primary care physicians. Patient Educ Couns. 2005;57(1): 77-87. (Pubitemid 40431915)
29. National Kidney Disease Education P. Health professionals. http:// nkdep.nih.gov/professionals/index.htm. Accessed July 17, 2009.
30. Boulware LE. Challenges for public campaigns to improve the health of persons at high risk of developing CKD. Am J Kidney Dis. 2008;51 (4): 535-8. (Pubitemid 351400849)
31. Niederdeppe J, Levy AG. Fatalistic beliefs about cancer prevention and three prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2007;16 (5): 998-1003. (Pubitemid 46910103)
32. Farmer D, Reddick B, D'Agostino R, Jackson SA. Psychosocial correlates of mammography screening in older African American women. Oncol Nurs Forum. 2007;34(1): 117-23.
33. Russell KM, Perkins SM, Zollinger TW, Champion VL. Sociocultural context of mammography screening use. Oncol Nurs Forum. 2006;33 (1): 105-12. (Pubitemid 44870016)
34. Greiner KA, James AS, Born W, et al. Predictors of fecal occult blood test (FOBT) completion among low-income adults. Prev Med. 2005;41 (2): 676-84. (Pubitemid 40732385)
35. Burkhart PV, Rayens MK. Self-concept and health locus of control: factors related to children's adherence to recommended asthma regimen. Pediatr Nurs. 2005;31(5): 404-9.
36. Cvengros JA, Christensen AJ, Lawton WJ. The role of perceived control and preference for control in adherence to a chronic medical regimen. Ann Behav Med. 2004;27(3): 155-61. (Pubitemid 38737971)
37. O'Hea EL, Grothe KB, Bodenlos JS, Boudreaux ED, White MA, Brantley PJ. Predicting medical regimen adherence: the interactions of health locus of control beliefs. J Health Psychol. 2005;10(5): 705-17. (Pubitemid 41192355)
38. Dunbar-Jacob JM, Schlenk EA, Burke LE, Matthews JT. Predictors of patient adherence: patient characteristics. In: Schumamer SA, Schron EB, Ockene JK,McBee WL, eds. The Handbook of Health Behavior Change. 2nd ed. New York: Springer Publishing Company; 1998: 491-511.
39. Glanz K, Lewis FM, Rimer BK. Part Two: Models of Indivudial Health Behavior. Health Behavior and Health Education. Theory, Research and Practice. San Francisco: Jossey-Bass, Inc.; 1997.
40. DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45 (6): 521-8.
41. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18): 1837-47. (Pubitemid 28213628)
42. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22 (3): 312-8.
43. Officers A, Coordinators for the ACRG. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002;288(23):2998-3007.
44. Rahman M, Pressel S, Davis BR, et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165(8): 936-46. (Pubitemid 40563242) Kidney Diseases Diseases